Ex Parte Miller et alDownload PDFPatent Trial and Appeal BoardJul 25, 201813287596 (P.T.A.B. Jul. 25, 2018) Copy Citation UNITED STA TES p A TENT AND TRADEMARK OFFICE APPLICATION NO. FILING DATE 13/287,596 11/02/2011 6147 7590 07/27/2018 GENERAL ELECTRIC COMPANY GPO/GLOBAL RESEARCH 901 Main Avenue 3rd Floor Norwalk, CT 06851 FIRST NAMED INVENTOR Scott Michael Miller UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www .uspto.gov ATTORNEY DOCKET NO. CONFIRMATION NO. 241262-2 1353 EXAMINER GALISTEO GONZALE, ANTONIO ART UNIT PAPER NUMBER 1636 NOTIFICATION DATE DELIVERY MODE 07/27/2018 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): haeckl@ge.com gpo.mail@ge.com Lori.e.rooney@ge.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte SCOTT MICHAEL MILLER, YOSANG YOON, SLA WOMIR RUBINSZTAJN, PETER KENNEDY DA VIS, and PRAMEELA SUS ARLA 1 Appeal2017-004012 Application 13/287,596 Technology Center 1600 Before JEFFREY N. FREDMAN, JOHN G. NEW, and RICHARD J. SMITH, Administrative Patent Judges. NEW, Administrative Patent Judge. DECISION ON APPEAL 1 Appellants state that the real party-in-interest is General Electric Company. App. Br. 2. Appeal2017-004012 Application 13/287 ,596 SUMMARY Appellants file this appeal under 35 U.S.C. § I34(a) from the Examiner's Final Rejection of claims 1-17. Specifically, claims 1-9, 11, and 12 stand rejected as unpatentable under 35 U.S.C. § I02(b) as being anticipated by Chan et al. (US 2009/0248145 A 1, October 1, 2009) ("Chan"). Claims 1-12 stand rejected as unpatentable under 35 U.S.C. § I03(a) as being obvious over the combination of Chan and Okano et al. (US 2003/0036196 Al, February 20, 2003) ("Okano"). Claims 1-9, 11-15, and 17 stand rejected as unpatentable under 35 U.S.C. § I03(a) as being obvious over the combination of Chan and Fryer et al. (WO 2009/105570 A2, August 27, 2009) ("Fryer"). Claims 1-9, 11, 12, and 16 stand rejected as unpatentable under 35 U.S.C. § I03(a) as being obvious over the combination of Chan and S. Fujita et al., Time-lapse Observation of Cell Alignment on Nanogrooved Patterns, 6 J. R. Soc. INTERFACE S269-77 (2009) ("Fujita"). Claims 1-17 also stand provisionally rejected as unpatentable under the judicially-created doctrine of obviousness-type double patenting over claims 1, 3, 5-12, 17, and 18 of Appellants' copending US Ser. No. 12/970,735 and Fujita. We have jurisdiction under 35 U.S.C. § 6(b). We AFFIRM. 2 Appeal2017-004012 Application 13/287 ,596 NATURE OF THE CLAIMED INVENTION Appellants' invention is directed to a carrier for growing adherent cells, comprising one or more surfaces and one or more relief features on one or more of the surfaces. Abstract. REPRESENTATIVE CLAIM Claim 1 is representative of the claims on appeal and recites: 1. A carrier for growing adherent cells, comprising: one or more surfaces; and one or more relief features on one or more of the surfaces, wherein the carrier has a length at least about 0.2 mm, a width at least about 0.2 mm, and a height in a range from about 0.012 mm to 0.5 mm; and wherein each of the relief features has a height in a range from about 2 to 200 µm, and width in a range from about 20 to 200 µm. App. Br. 17. ISSUES AND ANALYSES We are persuaded by, and expressly adopt, the Examiner's findings and conclusions establishing that Appellants' claims are prima facie anticipated by, or obvious over, the combined cited prior art. We address the arguments raised by Appellants below. 3 Appeal2017-004012 Application 13/287 ,596 A. Claims 1-9, 11, and 12 under 35 U.S.C. § I02(b) over Chan Issue 1 Appellants argue these claims together. App. Br. 9. Appellants argue that the Examiner erred because Chan does not anticipate the overall length or width of the substrate, as recited in claim 1. App. Br. 10. Analysis Appellants dispute the Examiner's reliance upon, inter alia, Figure 4A of Chan, of which the Examiner finds that: "since the microchannel can comprise the whole surface of the substrate as shown in figure 4A, the width of the microchannel is up to 0.8 mm, and the lateral walls can form a cube, the width and length of the microchannel can be up to I mm." App. Br. 10 ( quoting Final Act. 5). According to Appellants, as a matter of law, proportions of features in a drawing are not evidence of actual proportions when drawings are not to scale, and one cannot therefore presume the dimensions from a drawing. Id. ( citing MPEP § 2125). Appellants further question the Examiner's reliance upon Figure 6b of Chan, arguing that Figure 6b a cross-sectional view of a part of the substrate with its microchannel. App. Br. 10-11. Appellants contend that the overall substrate dimension cannot be derived from this image, and that the overall size of the substrate is not disclosed by Chan. Id. at 11. We disagree with Appellants' contention that Chan fails to disclose the overall length or width of the substrate. Claim 1 recites, in relevant part: "wherein the carrier has a length at least about 0.2 mm, a width at least about 4 Appeal2017-004012 Application 13/287 ,596 0.2 mm." Figure 12 of Chan (which is also reproduced on the cover page of Chan) is reproduced below: Figure 12 of Chan illustrates the four most common folding directions (I-IV) with respect to the microchannels (5), in which cells (I) are grown. Figure 12 of Chan expressly indicates that the intervals between the walls of Chan's microchannels range from 10-160 µm and that the maximum length of the carrier with four microchannels as illustrated is therefore at least 640 µm (0.64 mm), which exceeds the minimum length of "at least 0.2 mm," recited in claim 1. Chan also teaches that: "[i]n typical embodiments the microchannel is open along its length in that it defines a trench ( as opposed to a sub-surface channel)," and that "[t]he microchannel may be of any length." Chan ,r,r 43, 45 (emphasis added). Further employing the scale indicated in Figure 12 discloses that, in this embodiment, the width of the carrier is at least 480 µm (0.48 mm), which likewise exceeds the minimum of 0.2 mm recited in the claim. We consequently agree with the Examiner that Chan discloses the overall length or width of the substrate. While the Court states "arguments based on drawings not explicitly made to scale in issued patents are 5 Appeal2017-004012 Application 13/287 ,596 unavailing," the drawings in Chan expressly disclose a scale and therefore the facts here are distinguished from cases where no scale is provided. See Nystrom v. Trex Co., Inc., 374 F.3d 1105, 1117 (Fed. Cir. 2004). Issue 2 Appellant argues that the Examiner erred because Chan does not disclose any relief features. App. Br. 11. Analysis Appellants argue that Chan discloses a substrate with a microchannel, in which the microchannel is defined by at least a pair of opposing lateral walls and a base. App. Br. 11 (citing Chan Abstr.). Appellants quote the Examiner's finding that: "[t]he microchannel may possess a transverse section of any desired profile, such as being a cuboid (paragraph [0044])." Id. Appellants contend that the transverse section of Chan's microchannel are not the "relief features" recited in claim 1. Id. Furthermore, Appellants argue, the transverse section in Chan's microchannel clearly are not relief features having a height in a range from about 2 to 200 µm, and width in a range from about 20 to 200 µm. Appellants assert that no such dimensions are disclosed by Chan, either in the detailed description of the invention, the examples, or in any of the Figures. Id. We are not persuaded by Appellants' argument. Appellants' Specification discloses: One or more relief features are designed on the carrier surface, for example, as shown in FIG. 1. The relief feature comprises a height and a width, wherein the height is in a range from about 2 to 200 µm, and width is in a range from about 20 to 200 µm. In 6 Appeal2017-004012 Application 13/287 ,596 one or more embodiments, a distance between every two relief features is in a range of about 50 to 1000 µm. Spec. ,r 31. Figure 1 of Appellants' Specification is reproduced below: Figure 1 of Appellants' Specification depicts a cell carrier comprising a plurality of relief features showing dimensions of the carrier and each relief feature. Figure 6b of Chan is reproduced below, for purposes of comparison: Figure 6b2 of Chan depicts a cross-sectional view of the substrate with microchannels used in an embodiment of the invention. We agree with the Examiner that the "walls" of the contiguous microchannels, which extend upwards vertically from the "floor" of the 2 We note that Figure 6b of Chan shows a scale line that is 50 µm in length. 7 Appeal2017-004012 Application 13/287 ,596 microchannels in Chan's Figure 6b, correspond to the "relief features" of claim 1, as depicted in Figure 1 of Appellants' Specification. Claim 1 recites, in relevant part, that: "each of the relief features has a height in a range from about 2 to 200 µm, and width in a range from about 20 to 200 µm." Chan expressly discloses that: A wall that is shared by two contiguous microchannels [ as depicted, e.g., in Figure 6b] may be of any width. As an illustrative example, the width may be in the range, but not limited thereto, of from about 1 µm to about 100 µm, such as e.g. about 5 µm, about 10 µm, about 25 µm or about 50 µm. Chan ,r 46. Chan further expressly discloses that, in Figure 6b: "A common wall separating two channels is -25 µm wide .... The depth of a channel is 60 µm." Id. at ,r 74. We equate the "height" of the relief feature recited in claim 1 with the "depth" of the microchannel in Chan and the "width" of the relief feature of claim 1 to the "width" of the wall separating two microchannels, and we consequently determine that Chan discloses a range of height and width of the relief features recited in the claims. We consequently affirm the Examiner's rejection of claims 1-9, 11, and 12 upon this ground. B. Claims 1-12 under 35 U.S.C. § 103(a) over Chan and Okano Issue Appellants argue that Chan and Okano do not teach or suggest the recited limitations of the claims, and that the references cannot properly be combined. App. Br. 12. 8 Appeal2017-004012 Application 13/287 ,596 Analysis As we have explained supra, Chan discloses all of the limitations of claims 1-9, 11, and 12. We therefore conclude, for the same reasons, that these claims are obvious over Chan. See In re Kalm, 378 F.2d 959, 962 (C.C.P.A. 1967) (Anticipation is the epitome of obviousness). Furthermore, to the extent that, upon review by our superior court the claims are found to be not anticipated by Chan, we find that the range of the dimensions of length and width provided in Figure 12 of Chan substantially overlap those recited in claim 1. As such, we conclude that the claims are obvious over the teachings of Chan. See In re Peterson, 315 F.3d 1325, 1329 (Fed. Cir. 2003) ("In cases involving overlapping ranges, we and our predecessor court have consistently held that even a slight overlap in range establishes a prima facie case of obviousness"). That leaves claim 10 remaining on this ground of rejection. Claim 10 depends, ultimately, from claim 1 and recites: "The carrier of claim 8, wherein the coating comprises a thermoresponsive polymer, pH responsive polymer, or combination thereof." App. Br. 18. The Examiner finds that Okano teaches a cell carrier coated with a thermoresponsive polymer (bed material for cell culture having a surface composed of domain A coated with a temperature-responsive polymer. Final Act. 10 (citing Okano Abstr.). The Examiner also finds Okano teaches that such a coating allows detaching cells and reseeding the carrier by changing the temperature. Id. ( citing Okano ,r 31 ). Appellants argue that Chan and Okano cannot be combined. App. Br. 12. According to Appellants, the suggested combination of Okano and Chan would require substantial reconstruction and redesign of the elements shown 9 Appeal2017-004012 Application 13/287 ,596 in Chan's substrate as well as a change in the basic principle under which Chan's substrate was designed to operate to form a three-dimensional structure of unidirectionally aligned cells. Id. at 12-13. Furthermore, Appellants argue, Chan's substrate is merely a stationary, microfluidic device with microchannels for growing cells in one direction, which is in stark contrast to the carrier of claim 1 that is designed and sized for growing cells on small, lightweight substrates that are suspended in a liquid. Id. at 13. We are not persuaded by Appellants' arguments. The Examiner concluded that: [I]t would have been obvious to a person of ordinary skill in the art at the time of the invention to have the carrier described by [Chan] and coat it with a thermoresponsive polymer as described by Okano et al. to obtain a coated carrier. A person of ordinary skill in the art would be motivated to do so in order to detach cells and reseed the carrier by changing the temperature. Final Act. 10. Appellants have adduced no evidence of record that the teachings of Okano and Chan cannot be combined to provide a cell carrier with a thermoresponsive coating. As such, we accord little probative weight to their arguments. See In re Geisler, 116 F.3d 1465, 1470 (Fed. Cir. 1997) ( Attorney arguments and conclusory statements that are unsupported by factual evidence are entitled to little probative value). Furthermore: The test for obviousness is not whether the features of a secondary reference may be bodily incorporated into the structure of the primary reference; nor is it that the claimed invention must be expressly suggested in any one or all of the references. Rather, the test is what the combined teachings of 10 Appeal2017-004012 Application 13/287 ,596 the references would have suggested to those of ordinary skill in the art." In re Keller, 642 F.2d 413,425 (C.C.P.A. 1981). In this instance, the Examiner has stated a sufficiently rational motivation for a person of ordinary skill in the art to combine the teachings of Chan and Okano, viz., to be able to detach cells and reseed the carrier by changing the temperature. Appellants have failed to adduce any evidence of record to overcome the Examiner's findings and primafacie conclusion of obviousness. We consequently affirm the Examiner's rejection of the claims. C. Claims 1-9, 11-15, and 17 under 35 U.S.C. § 103(a) over Chan and Issue Appellants argue that the Examiner erred because Fryer does not cure the alleged deficiencies of Chan. App. Br. 13. Analysis As we have explained supra, claims 1-9, 11, and 12 are anticipated by, and obvious over, the teachings of Chan. Claims 13-15 and 17 thus 11 Appeal2017-004012 Application 13/287 ,596 remain to be considered on this ground. Claims 14 and 15 depend from claim 1 and are representative, and recite: 14. A kit for culturing cells, comprising a disposable housing pre-loaded with the carrier of claim 1. 15. The kit of claim 14, wherein the disposable housing is a bag, a flask, a tube, a petri dish, or a bottle. App. Br. 18. The Examiner finds Fryer teaches a kit for culturing stem cells comprising a disposable housing pre-loaded with a cell carrier. Final Act. 12. The Examiner finds Fryer teaches that the disposable housing is a bag, and that the surface modified plates were prepared by treating injection- molded items using a corona plasma treatment or a microwave plasma treatment. Id. ( citing Fryer Table 6). The Examiner finds that Chan teaches that the polymer materials used in injection molding is polystyrene and that the surface modified plates were individually packed in plastic bags, then sterilized by gamma irradiation and finally stored at room temperature until used in cell culture or surface characterization experiments. Id. ( citing Fryer Appellants argue that a person of ordinary skill in the art would not have had a reason to combine the substrate of Chan with the plastic bags of Fryer because such a combination would render the cell culture system and method of Chan inoperable. App. Br. 14. Specifically, Appellants point out that Chan teaches that: "contact guidance cues are provided by the pair of opposing lateral walls of the microchannel, such that the cells aligned unidirectionally." Id. (quoting Chan Abstr.). Appellants therefore argue that Chan suggests that a unidirectional movement of media through the 12 Appeal2017-004012 Application 13/287 ,596 microchannel is desired for growing unidirectionally-aligned cells, and that the disadvantage of culturing cells for Chan using dynamic bioreactor is that the unidirectional motion of media would not be maintained and probability of disruption of the three dimensional structure of unidirectionally-aligned cells in dynamic bioreactor. Id. Furthermore, argue Appellants, the carriers which are packed in disposable housing are configured to be used under suspension culture, which is not possible for Chan, as Chan's unidirectional cell alignment may not be maintained in suspension culture. Id. We are not persuaded by Appellants' arguments. Fryer teaches: "The surface modified plates were individually packed in plastic bags, then sterilized by gamma irradiation (25 kGy), and finally stored at room temperature until used in cell culture or surface characterization experiments." Fryer ,r 216. Fryer also teaches that: "Surface modified plates 1--4 and 13 were individually packed in plastic bags, sterilized, and stored at room temperature throughout the test period." Id. at ,r 220; see also ,r 255. The Examiner thus relies upon Fryer as teaching simply the use of bags as a means of sterile storage of cell culture plates until ready for use. It is not necessary, in this instance, for the all of the teachings of Fryer to be physically combinable with those of Chan beyond this limitation. See Keller, 642 F.2d at 425. We therefore agree with the Examiner that a person of ordinary skill would be motivated to combine the teachings of Fryer and Chan such that the prepared plates of Chan could be stored in a sterile manner prior to their use, as taught by Fryer. See Final Act. 12. We consequently affirm the Examiner's rejection of claims 1-9, 11-15, and 17 upon this ground 13 Appeal2017-004012 Application 13/287 ,596 D. Claims 1-9, 11, 12, and 16 under 35 U.S.C. § 103(a) over Chan and Issue Appellants argue the Examiner erred because neither Chan nor Fujita teach or suggest the carrier of claims 1-9, 11, 12, or of claim 16, in which the cells are human mesenchymal stromal cells (hMSC), Chinese hamster ovary (CHO) cells, Madin-Darby canine kidney (MDCK) cells, or Vero cells. App. Br. 15. Analysis As we have explained supra, claims 1-9, 11, and 12 are anticipated by, and obvious over, the teachings of Chan. Claim 16 alone, therefore, remains to be scrutinized upon this ground. Claim 16 recites: "The carrier of claim 1, wherein the cells are human mesenchymal stromal cells (hMSC), Chinese hamster ovary (CHO) cells, Madin-Darby canine kidney (MDCK) cells, or Vero cells." App. Br. 18. Appellants assert that Fujita teaches seeding MSCs on polycarbonate plates that were 20 mm in diameter and 3 mm thick, which, Appellants argue, teaches away from the carrier with relief features recited in claim 1. App. Br. 15. Furthermore, Appellants contend, Fujita neither teaches nor suggests a relief feature on the carrier, nor the specific dimensions of the carrier and the relief features. Id. Appellants contend that it would not be obvious without impermissibly applying hindsight reasoning to modify Chan, or to combine Chan with Fujita, to arrive at the carrier of claims 16. Id. 14 Appeal2017-004012 Application 13/287 ,596 We are not persuaded. We have already explained, in Section A supra, why we find that Chan teaches the dimensions and the relief features recited in claim 1. Chan is directed to the culture of cells on its carriers, and expressly teaches: Any cell may generally be selected to be seeded into the microchannel. However, in the method of the invention cells are selected that can align unidirectionally. Examples of respective cells include, but are not limited to, smooth muscle cells, skeletal muscle cells, endothelial cells, stem cells, progenitor cells, myocytes, bone marrow cells, neurons, pericytes and fibroblasts. Cells used in the method of the present invention may be of any source. Chan ,r 50 ( emphasis added). Fujita teaches the culturing of aligned, human bone marrow-derived mesenchymal stroma cells ("MSCs") on nanogrooved patterns. Fujita s269, s270. We agree with the Examiner that a person of ordinary skill would be motivated, with a reasonable expectation of success, to combine the teachings of Chan and Fujita. Chan teaches that stem cells that can align unidirectionally are suitable for its methods, and Fujita teaches that human mesenchymal stem cells, as recited in Appellants' claim 16, are capable of self-aligning in culture. Appellants suggest that Fujita teaches away from Appellants' claimed carrier, because Fujita employs a different cell carrier surface. See App. Br. 15. We disagree. First, the Examiner finds, and we agree (as we have explained in Section A), that Chan teaches the claimed carrier; the Examiner relies upon Fujita as teaching the culture of human mesenchymal stem cells, and the teachings of Chan expressly invite the culture of such stem cells. See Chan ,r 50. "[O]ne cannot show non-obviousness by attacking 15 Appeal2017-004012 Application 13/287 ,596 references individually where ... the rejections are based on combinations of references." Keller, 642 F.2d at 426. Second, a reference teaches away when "a person of ordinary skill, upon reading the reference, would be discouraged from following the path set out in the reference, or would be led in a direction divergent from the path that was taken by the applicant." In re Gurley, 27 F.3d 551, 553 (Fed.Cir.1994). Appellants adduce no evidence of record, nor can we discern any, that would discourage or divert an artisan of ordinary skill from culturing human MSCs in the carrier of Chan, as expressly contemplated by Chan. We do not agree, therefore, that Fujita teaches away from Appellants' claimed invention. Finally, with respect to Appellants' allegation that the Examiner impermissibly employed hindsight reasoning to arrive at the conclusion that the claims are obvious over the cited prior art: Any judgment on obviousness is in a sense necessarily a reconstruction based upon hindsight reasoning, but so long as it takes into account only knowledge which was within the level of ordinary skill at the time the claimed invention was made and does not include knowledge gleaned only from applicant's disclosure, such a reconstruction is proper. In re McLaughlin, 443 F.2d 1392, 1395 (C.C.P.A. 1971). Appellants have pointed to no limitation of the claims on appeal that could only have been derived only from Appellants' Specification and not from the combined teachings of the cited prior art. We consequently affirm the Examiner's rejection of the claims 1-9, 11, 12, and 16 upon this ground. 16 Appeal2017-004012 Application 13/287 ,596 D. Claims 1-17 under the doctrine of obviousness-type double patenting Appellants request that the obviousness-type double patenting rejection be held in abeyance until patentable subject matter has been identified. App. Br. 16. However, because we affirm the Examiner's rejection of claims 1-17 under 35 U.S.C. §§ 102(b) and/or 103(a), and because Appellants do not argue the merits of the Examiner's rejection upon this ground, we summarily affirm the Examiner's rejection of claims 1-17 under the nonstatutory doctrine of obviousness-type double patenting. DECISION The Examiner's rejection of claims 1-9, 11, and 12 under 35 U.S.C. § 102(b) is affirmed. The Examiner's rejection of claims 1-17 under 35 U.S.C. § 103(a) is affirmed. The Examiner's rejection of claims 1-17 under the nonstatutory doctrine of obviousness-type double patenting is affirmed. No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a)(l )(iv). AFFIRMED 17 Copy with citationCopy as parenthetical citation